Breaking News

PPD Adds New Central Lab Services

February 8, 2013

Brussels, Singapore sites now offer microbiology capabilities

Pharmaceutical Product Development, LLC (PPD) has expanded its central lab testing services in infectious diseases at its Brussels and Singapore labs, offering additional microbiology, peripheral blood mononuclear cell and molecular pathology services.
PPD's labs in Brussels and Singapore now offer a full range of microbiology testing services for bacteriology, mycology, parasitology and microbioterrorism pathogens, and can conduct extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and SNP analysis. The labs also have the capability to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms.
"Adding these services to our Brussels and Singapore labs expands our ability to provide clients in Europe and Asia Pacific an important component of laboratory testing for infectious diseases," said Elena Logan, senior vice president of central labs for PPD. "PPD is unique in that we offer fully integrated clinical trial management and central laboratory services, enabling us to provide increased efficiencies, greater study flexibility and added value to our clients."